Benchmarking dosimetric quality assessment of prostate intensity-modulated radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages 998-1005

  Senthi, Sashendra ^a   Gill, Suki S ^a   Haworth, Annette ^a   Kron, Tomas ^a   Cramb, Jim ^a   Rolfo, Aldo ^a   Thomas, Jessica ^a   Duchesne, Gillian M ^a   Hamilton, Christopher H ^b   Joon, Daryl Lim ^b   Bowden, Patrick ^c   Foroudi, Farshad ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b AUSTIN HEALTH   (Australia)

^c Radiation Oncology Department   (Australia)

Author keywords

Dosimetry; IMRT; Intensity modulated radiotherapy; Prostate; Quality assurance; Target coverage

Indexed keywords

ANDROGEN DEPRIVATION THERAPY; CLINICAL TARGET VOLUMES; CONFIDENCE INTERVAL; CONFORMITY INDEX; COVERAGE FACTORS; HEALTHY TISSUES; IMRT; INTENSITY-MODULATED RADIOTHERAPY; MULTIVARIATE REGRESSION MODELS; PLAN QUALITY; PLANNING SYSTEMS; PLANNING TARGET VOLUMES; PROSTATE; PROSTATE CANCERS; QUALITY ASSESSMENT; RADIOTHERAPY TREATMENT; TARGET COVERAGE; TUMOR COVERAGE;

BENCHMARKING; DOSIMETERS; DOSIMETRY; PHYSICAL THERAPY; QUALITY ASSURANCE; RADIOTHERAPY; REGRESSION ANALYSIS; TISSUE;

DISEASES;

PROSTATE SPECIFIC ANTIGEN;

AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; DOSIMETRY; HEALTH CARE PLANNING; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; RADIATION DOSE; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; BENCHMARKING; CONFIDENCE INTERVALS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANS AT RISK; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TUMOR BURDEN; VICTORIA;

EID: 84855831963     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.12.016     Document Type: Article

References (28)

1. S.T. Peeters, W.D. Heemsbergen, and P.C. Koper Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996
2. A. Pollack, G.K. Zagars, and G. Starkschall Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105
3. A.L. Zietman, M.L. DeSilvio, and J.D. Slater Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial JAMA 294 2005 1233 1239
4. D.P. Dearnaley, M.R. Sydes, and J.D. Graham Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial Lancet Oncol 8 2007 475 487
5. P.B. Morgan, A.L. Hanlon, and E.M. Horwitz Radiation dose and late failures in prostate cancer Int J Radiat Oncol Biol Phys 67 2007 1074 1081
6. R. Valicenti, J. Lu, and M. Pilepich Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials J Clin Oncol 18 2000 2740 2746
7. G.E. Hanks, A.L. Hanlon, and B. Epstein Dose response in prostate cancer with 8-12 years' follow-up Int J Radiat Oncol Biol Phys 54 2002 427 435
8. M.J. Zelefsky, E.J. Levin, and M. Hunt Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124 1129
9. International Commission on Radiation Units and Measurements Report no. 50: Prescribing, recording, and reporting photon beam therapy 1993 ICRU Bethesda
10. International Commission on Radiation Units and Measurements Report no. 62 (supplement to ICRU report 50): Prescribing, recording and reporting photon beam therapy 1999 ICRU Bethesda
11. I.J. Das, C.W. Cheng, and K.L. Chopra Intensity-modulated radiation therapy dose prescription, recording, and delivery: Patterns of variability among institutions and treatment planning systems J Natl Cancer Inst 100 2008 300 307
12. L.J. Peters, B. O'Sullivan, and J. Giralt Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: Results from TROG 02.02 J Clin Oncol 28 2010 2996 3001
13. J.M. Galvin, G. Ezzell, and A. Eisbrauch Implementing IMRT in clinical practice: A joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine Int J Radiat Oncol Biol Phys 58 2004 1616 1634
14. National Cancer Institue, Clinical Radiation Oncology Branch NCI guidelines for the use of IMRT in clinical trials 2006 National Cancer Institute Bethesda
15. T. Holmes, R. Das, and D. Low American Society of Radiation Oncology recommendations for documenting intensity-modulated radiation therapy treatments Int J Radiat Oncol Biol Phys 74 2009 1311 1318
16. International Commission on Radiation Units and Measurements Report no. 83: Prescribing, recording, and reporting intensity-modulated photon-beam therapy (IMRT) 2010 ICRU Bethesda
17. C. Burman, C.S. Chui, and G. Kutcher Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate Int J Radiat Oncol Biol Phys 39 1997 863 873
18. M. Yoon, S.Y. Park, and D. Shin A new homogeneity index based on statistical analysis of the dose-volume histogram J Appl Clin Med Phys 8 2007 9 17
19. Lefkopoulos DSM, Touboul E, et al. Quantitative evaluation of treatment planning for linac multi-isocentric radiosurgery. Proceedings of the XIth International Conference on Computers in Radiation Therapy, XIth ICCR, Manchester, UK 1994.
20. Lefkopoulos D DC, El-Balma H, et al. Determination of dose-volumes parameters to characterise the conformity of stereotactic treatment plans. Proceedings of the XIIIth International Conference on Computers in Radiation Therapy, XIIIth ICCR, Heidelberg, Germany. 2000.
21. N.J. Lomax, and S.G. Scheib Quantifying the degree of conformity in radiosurgery treatment planning Int J Radiat Oncol Biol Phys 55 2003 1409 1419
22. A. van't Riet, A.C. Mak, and M.A. Moerland A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: Application to the prostate Int J Radiat Oncol Biol Phys 37 1997 731 736
23. A.V. D''Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
24. G.S. Merrick, W.M. Butler, and A.T. Dorsey Potential role of various dosimetric quality indicators in prostate brachytherapy Int J Radiat Oncol Biol Phys 44 1999 717 724
25. RTOG 0126 protocol. A phase III randomized study of high dose 3D-CRT/IMRT versus standard dose 3D-CRT/IMRT in patients treated for localized prostate cancer. 2004. http://www.rtog.org/members/protocols/0126/p0126.pdf; Accessed 15/06/2010.
26. RTOG 0521 protocol. A phase III protocol of androgen suppression (AS) and 3DCRT/IMRT vs AS and 3DCRT/IMRT followed by chemotherapy with docetaxel and prednisone for localized, high-risk prostate cancer. 2005. http://www.rtog.org/ members/protocols/0521/0521.pdf; Accessed 15/06/2010.
27. T. Bortfeld, D. Craft, and J.F. Dempsey Evaluating target cold spots by the use of tail EUDs Int J Radiat Oncol Biol Phys 71 2008 880 889
28. C.C. Schulman, F.M. Debruyne, G. Forster European Study Group on Neoadjuvant Treatment of Prostate Cancer 4-Year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer Eur Urol 38 2000 706 713